Bender Robert & Associates Astrazeneca PLC Transaction History

Bender Robert & Associates

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$63.2 - $79.58 $106,176 - $133,694	-1,680 Reduced 12.1%	12,202 $799,000
Q3 2024 Oct 30, 2024	BUY	$76.67 - $87.62 $1.06 Million - $1.22 Million	13,882 New	13,882 $1.08 Million
Q1 2024 Apr 22, 2024	SELL	$61.03 - $69.57 $266,395 - $303,673	-4,365 Reduced 18.83%	18,813 $1.27 Million
Q4 2023 Jan 31, 2024	SELL	$61.89 - $69.28 $336,743 - $376,952	-5,441 Reduced 19.01%	23,178 $1.56 Million
Q3 2023 Oct 13, 2023	SELL	$64.85 - $71.7 $193,058 - $213,450	-2,977 Reduced 9.42%	28,619 $1.94 Million

Q2 2023 Jul 13, 2023	SELL	$69.91 - $75.81 $885,340 - $960,057	-12,664 Reduced 28.61%	31,596 $2.26 Million
Q1 2023 Apr 20, 2023	BUY	$63.15 - $71.6 $1,894 - $2,148	30 Added 0.07%	44,260 $3.07 Million
Q4 2022 Feb 02, 2023	SELL	$54.21 - $70.44 $118,448 - $153,911	-2,185 Reduced 4.71%	44,230 $3 Million
Q3 2022 Oct 26, 2022	BUY	$53.02 - $135.75 $50,952 - $130,455	961 Added 2.11%	46,415 $2.55 Million
Q2 2022 Jul 19, 2022	SELL	$59.26 - $71.14 $52,385 - $62,887	-884 Reduced 1.91%	45,454 $3 Million
Q1 2022 Apr 14, 2022	SELL	$55.72 - $67.12 $13,428 - $16,175	-241 Reduced 0.52%	46,338 $3.07 Million
Q3 2021 Nov 03, 2021	BUY	$55.56 - $60.79 $2.59 Million - $2.83 Million	46,579 New	46,579 $2.8 Million

1,501

501M

5.59M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Bender Robert & Associates, based on Form 13F filings with the SEC.

Stay updated on Bender Robert & Associates with notifications on news.